Delivery Order SPE2DB22D9133-SPE2DB23FYY25
- Not listed
- The Defense Logistics Agency awarded a $14,928.66 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products and services to various Department of Defense components. DMS Pharmaceutical will deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a facility in Park Ridge,...
- The Defense Logistics Agency awarded a $20,712 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the Department of Defense. DMS will deliver 20mL vials of the specified anesthetic to a facility in Park Ridge, Illinois, completing performance by September 25, 2023. No set aside designation or subcontractors were identified. The Defense...
- The Defense Logistics Agency awarded a delivery order valued at approximately $7,464 to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois. The order was issued against an existing DLA contract vehicle and has a period of performance from July 5, 2023 through July 26, 2023. As the...
- The Defense Logistics Agency awarded a $29,857 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois. Funding is provided by DLA in support of Department of Defense requirements. The order has a period of performance from August 1, 2023 through August 22, 2023 and...
- The Defense Logistics Agency awarded a $49,762.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for EXPAREL 266 MG/20 ML vials. Under this order, DMS Pharmaceutical will deliver 20 mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois by September 27, 2023 in support of Department of Defense requirements. No set aside designation or subcontractors were identified. This order was issued against an...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $10,000 to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the agency's medical supply needs. DMS Pharmaceutical will deliver 20mL vials of the specified anesthetic to a facility in Park Ridge, Illinois, completing performance within three weeks of the April 3rd start date. No...
- The Defense Logistics Agency, on behalf of the Department of Defense, awarded a $99,524 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an unspecified government-wide acquisition contract vehicle. DMS Pharmaceutical will deliver 20mL vials of the specified anesthetic to a facility in Park Ridge, Illinois, with performance required between August 1st and 22nd, 2023. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a $29,857 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois by September 29, 2023. The Defense Logistics Agency will provide funding for this order placed under an undisclosed multiple award contract vehicle. No...
- The Defense Logistics Agency awarded a delivery order valued at approximately $10,000 to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois. Performance will take place between March 2nd and March 23rd, 2023. The Defense Logistics Agency manages the Department of Defense's global...
- The Defense Logistics Agency Troop Support Medical awarded a $24,881 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. DMS Pharmaceutical Group will deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to locations in Park Ridge, Illinois on dates between August 30 and September 21, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and distribution...
- SPE2DB22D9133Indefinite Delivery Contract
- SPE2DB22D9133-SPE2DB23FYY25Delivery Order
The Defense Logistics Agency awarded a $49,762.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products and services to various Department of Defense components. DMS Pharmaceutical will deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a facility in Park Ridge, Illinois. Performance is required between September 8 and 29, 2023. No socioeconomic designations or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the U.S. military and supports its stock readiness and contingency operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.8k | 9/8/23 |